BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9928075)

  • 1. Role of PACAP in the regulation of gonadotroph hormone secretion during ontogenesis: a single neonatal injection of PACAP delays puberty and its intracerebroventricular administration before the critical period of proestrous stage blocks ovulation in adulthood.
    Köves K; Molnár J; Kántor O; Lakatos A; Fógel K; Kausz M; Vandermeers-Piret MC; Somogyvári-Vigh A; Arimura A
    Ann N Y Acad Sci; 1998 Dec; 865():590-4. PubMed ID: 9928075
    [No Abstract]   [Full Text] [Related]  

  • 2. New aspects of the neuroendocrine role of PACAP.
    Köves K; Molnár J; Kántor O; Görcs TJ; Lakatos A; Arimura A
    Ann N Y Acad Sci; 1996 Dec; 805():648-54. PubMed ID: 8993455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of PACAP in gonadotropic hormone secretion at hypothalamic and pituitary levels.
    Köves K; Kántor O; Molnár J; Heinzlmann A; Szabó E; Szabó F; Nemeskéri A; Horváth J; Arimura A
    J Mol Neurosci; 2003 Apr; 20(2):141-52. PubMed ID: 12794308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PACAP participates in the regulation of the hormonal events preceeding the ovulation.
    Köves K; Molnár J; Kántor O; Lakatos A; Görcs TJ; Somogyvári-Vigh A; Fürst Z; Arimura A
    Acta Biol Hung; 1996; 47(1-4):239-49. PubMed ID: 9123995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal PACAP administration in rats delays puberty through the influence of the LHRH neuronal system.
    Szabó F; Horváth J; Heinzlmann A; Arimura A; Köves K
    Regul Pept; 2002 Nov; 109(1-3):49-55. PubMed ID: 12409214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of prolactin mRNA in the rat hypothalamus after intracerebroventricular injection of VIP or PACAP.
    Bredow S; Kacsóh B; Obál F; Fang J; Krueger JM
    Brain Res; 1994 Oct; 660(2):301-8. PubMed ID: 7820699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
    Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
    Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus.
    Grinevich V; Fournier A; Pelletier G
    Brain Res; 1997 Oct; 773(1-2):190-6. PubMed ID: 9409720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide on tolerance to morphine and alcohol in mice.
    Szabó G; Mácsai M; Schek E; Telegdy G
    Ann N Y Acad Sci; 1998 Dec; 865():566-9. PubMed ID: 9928071
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulatory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide on tuberoinfundibular dopaminergic neuron activity in estrogen-treated ovariectomized rats and their correlation with prolactin secretion.
    Huang SK; Pan JT
    Neuroendocrinology; 1996 Sep; 64(3):208-14. PubMed ID: 8875438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.
    Matsuda K; Maruyama K; Nakamachi T; Miura T; Uchiyama M; Shioda S
    Peptides; 2005 Sep; 26(9):1611-6. PubMed ID: 16112400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary adenylate cyclase-activating polypeptide (PACAP) potentiates the gonadotropin-releasing activity of luteinizing hormone-releasing hormone.
    Culler MD; Paschall CS
    Endocrinology; 1991 Oct; 129(4):2260-2. PubMed ID: 1915106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on mouse preantral follicle development in vitro.
    Cecconi S; Rossi G; Barberi M; Scaldaferri L; Canipari R
    Endocrinology; 2004 Apr; 145(4):2071-9. PubMed ID: 14701671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines.
    Masuo Y; Noguchi J; Morita S; Matsumoto Y
    Brain Res; 1995 Nov; 700(1-2):219-26. PubMed ID: 8624713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR; Piuz I; Schlegel W; Bockaert J; Journot L
    Endocrinology; 1995 May; 136(5):2088-98. PubMed ID: 7720658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of different receptors in pituitary adenylate cyclase activating polypeptide induced open field activity in rats.
    Adamik A; Telegdy G
    Neuropeptides; 2004 Feb; 38(1):16-20. PubMed ID: 15003711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase activating polypeptide enhances rapid eye movement sleep in rats.
    Fang J; Payne L; Krueger JM
    Brain Res; 1995 Jul; 686(1):23-8. PubMed ID: 7583267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient periovulatory expression of pituitary adenylate cyclase activating peptide in rat ovarian cells.
    Gräs S; Hannibal J; Georg B; Fahrenkrug J
    Endocrinology; 1996 Nov; 137(11):4779-85. PubMed ID: 8895347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenylate cyclase activation by VIP and PACAP in the retina and choroid: effects of antagonists.
    Nilsson SF; Amér M; Vandermeers A
    Ann N Y Acad Sci; 1996 Dec; 805():749-52. PubMed ID: 8993472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.